Welcome to Dr. Yong Chen's Research Lab!

🌟 Explore the Future of Cancer Research!

At the Chen Lab, we harness the power of bioinformatics and computational systems biology to decode the complexities of cancer. Our mission is to enhance understanding through innovative research methods, focusing on omics studies, chromatin interactions, and the discovery of clinical biomarkers.

Bioinformatics | Cancer Epigenetics | Chromatin Interaction |
Bioinformatics | Cancer Epigenetics | Chromatin Interaction |
background image
In Situ Capture of Chromatin Interactions by Biotinylated dCas9
Cis-regulatory elements (CREs) are commonly recognized by correlative chromatin features, yet the molecular composition of the vast majority of CREs in chromatin remains unknown. Here, we describe a CRISPR affinity purification in situ of regulatory elements (CAPTURE) approach to unbiasedly identify locus-specific chromatin-regulating protein complexes and long-range DNA interactions.
background image
Bioinformatics Innovations
Leveraging computational systems biology for biomarker discovery and precision medicine.
background image
Mathematical Modeling
Applying mathematical models to understand cancer biology and predict therapeutic outcomes.
background image
Omics and Data Integration
Integrating multi-omics data to map molecular pathways involved in cancer and therapeutic resistance.

News & Events

1
2023-10-15

Breakthrough in Gene Sequencing Algorithm

Our team has developed a new algorithm that significantly reduces the time required for gene sequencing.

Read more
2
2023-10-10

Upcoming Webinar: AI in Bioinformatics

Join us for a webinar discussing the latest applications of AI in bioinformatics research.

Read more
3
2023-10-05

New Research Grant Awarded

Our lab has been awarded a $2M grant to further our research in protein folding prediction.

Read more
4
2023-09-28

Publication in Nature Biotechnology

Our recent paper on CRISPR applications in rare genetic disorders has been published in Nature Biotechnology.

Read more
5
2023-09-20

Collaboration with Pharma Giant

We're excited to announce a new collaboration with a leading pharmaceutical company on drug discovery.

Read more